Anca-associated Vasculitis
📧 Sign up to get email alerts when something new happens for Anca-associated Vasculitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated Vasculitis
This clinical trial update reports on the immunogenicity of a combined anti-pneumococcal vaccine schedule in patients with ANCA-associated v…
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Abatacept in ANCA Associated Vasculitis [Phase 2]
A Phase 2 trial evaluating abatacept for ANCA-associated vasculitis has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-12-06Clinical Trial Update: Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis [Phase 2, Phase 3]
This entry notes a completed Phase 2/3 clinical trial comparing mycophenolate mofetil with cyclophosphamide in ANCA-associated vasculitis.
-
CLINICAL_TRIALS trial_result · 2010-06-08Clinical Trial Update: MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis [NA]
An update notes a completed trial comparing mycophenolate mofetil (MMF) versus cyclophosphamide (CTX) for induction therapy in ANCA-associat…
-
CLINICAL_TRIALS trial_result · 2007-10-10Clinical Trial Update: WEGENT - Comparison of Methotrexate or Azathioprine as Maintenance Therapy for ANCA-Associated Vasculitides [Phase 3]
Phase 3 trial update for WEGENT comparing methotrexate versus azathioprine as maintenance therapy in ANCA-associated vasculitis, including g…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2006-05-22Clinical Trial Update: Intravenous Immunoglobulin After Relapse in Vasculitis [Phase 3]
Phase 3 trial of intravenous immunoglobulin for relapse in ANCA-associated vasculitis was terminated.